Merck OTC Stock Today

MKKGY -  USA Stock  

USD 41.52  0.12  0.29%

Merck Kgaa is trading at 41.52 as of the 3rd of August 2021; that is 0.29 percent up since the beginning of the trading day. The stock's open price was 41.4. Merck Kgaa has about a 29 % chance of experiencing some form of financial distress in the next two years of operation and had a somewhat solid performance during the last 90 days. Equity ratings for Merck Kgaa ADR are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 5th of January 2021 and ending today, the 3rd of August 2021. Click here to learn more.
 Market Performance
18 of 100
  Odds Of Distress
Less than 29
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Merck Kgaa OTC Stock Profile

MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and performance materials sectors worldwide. MERCK Kommanditgesellschaft auf Aktien operates as a subsidiary of E. Merck Kgaa operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 57850 people. more on Merck Kgaa
Legal NameMerck Kgaa ADR
CEOUdit Batra  (View All)
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Merck Kgaa's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Strong BuyUndervalued
Merck Kgaa ADR [MKKGY] is traded as part of a regulated electronic over-the-counter service offered by the NASD. The company currently falls under 'Large-Cap' category with current market capitalization of 89.17 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Merck Kgaa's market, we take the total number of its shares issued and multiply it by Merck Kgaa's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Merck Kgaa ADR classifies itself under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 2.17 B outstanding shares. Merck Kgaa ADR has accumulated about 2.3 B in cash with 4.18 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.06.
Check Merck Kgaa Probability Of Bankruptcy
Ownership
Merck Kgaa ADR holds a total of 2.17 Billion outstanding shares. Roughly 100.0 % of Merck Kgaa outstanding shares are held by regular investors with 0.0 pct. owned by insiders and only 0.16 % by institutional investors. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.

Ownership Allocation (%)

Check Merck Ownership Details

Merck Stock Price Odds Analysis

What are Merck Kgaa's target price odds to finish over the current price? Based on a normal probability distribution, the odds of Merck Kgaa jumping above the current price in 90 days from now is nearly 4.7%. The Merck Kgaa ADR probability density function shows the probability of Merck Kgaa otc stock to fall within a particular range of prices over 90 days. Assuming the 90 days horizon Merck Kgaa has a beta of 0.6871. This indicates as returns on the market go up, Merck Kgaa average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Merck Kgaa ADR will be expected to be much smaller as well. Additionally, the company has an alpha of 0.2161, implying that it can generate a 0.22 percent excess return over DOW after adjusting for the inherited market risk (beta).
 Odds Down 41.52HorizonTargetOdds Up 41.52 
95.25%90 days
 41.52 
4.70%
Based on a normal probability distribution, the odds of Merck Kgaa to move above the current price in 90 days from now is nearly 4.7 (This Merck Kgaa ADR probability density function shows the probability of Merck OTC Stock to fall within a particular range of prices over 90 days) .

Merck Kgaa ADR Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. Merck Kgaa market risk premium is the additional return an investor will receive from holding Merck Kgaa long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Merck Kgaa. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Merck Kgaa's alpha and beta are two of the key measurements used to evaluate Merck Kgaa's performance over the market, the standard measures of volatility play an important role as well.

Merck Stock Against Markets

Picking the right benchmark for Merck Kgaa otc stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Merck Kgaa otc stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Merck Kgaa is critical whether you are bullish or bearish towards Merck Kgaa ADR at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Merck Kgaa without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Theme Ratings Now

   

Theme Ratings

Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
All  Next Launch Module

Merck Kgaa Corporate Management

Elected by the shareholders, the Merck Kgaa's board of directors comprises two types of representatives: Merck Kgaa inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Merck. The board's role is to monitor Merck Kgaa's management team and ensure that shareholders' interests are well served. Merck Kgaa's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Merck Kgaa's outside directors are responsible for providing unbiased perspectives on the board's policies.
Constantin Fest - Head of Investor RelationsProfile
Michaela Glenck - Member of the Supervisory BoardProfile
Veit Ulshoefer - Member of the Supervisory Board, Employee RepresentativeProfile
Gabriele Eismann - Member of the Supervisory Board, Employee RepresentativeProfile
Anke Schenkel - Head of Group Controlling & Risk ManagementProfile
Additionally, see Stocks Correlation. Note that the Merck Kgaa ADR information on this page should be used as a complementary analysis to other Merck Kgaa's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Complementary Tools for Merck OTC Stock analysis

When running Merck Kgaa ADR price analysis, check to measure Merck Kgaa's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Merck Kgaa is operating at the current time. Most of Merck Kgaa's value examination focuses on studying past and present price action to predict the probability of Merck Kgaa's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Merck Kgaa's price. Additionally, you may evaluate how the addition of Merck Kgaa to your portfolios can decrease your overall portfolio volatility.
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Equity Search
Search for activelly traded equities including funds and ETFs from over 30 global markets
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
The market value of Merck Kgaa ADR is measured differently than its book value, which is the value of Merck that is recorded on the company's balance sheet. Investors also form their own opinion of Merck Kgaa's value that differs from its market value or its book value, called intrinsic value, which is Merck Kgaa's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Merck Kgaa's market value can be influenced by many factors that don't directly affect Merck Kgaa ADR underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Merck Kgaa's value and its price as these two are different measures arrived at by different means. Investors typically determine Merck Kgaa value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Merck Kgaa's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.